Ecology and Evolution as Targets: the Need for Novel Eco-Evo Drugs and Strategies To Fight Antibiotic Resistance

被引:134
作者
Baquero, Fernando [1 ]
Coque, Teresa M. [1 ]
de la Cruz, Fernando [2 ]
机构
[1] Ramon y Cajal Univ Hosp, Dept Microbiol, Inst Ramon & Cajal Hlth Res IRYCIS, CIBER Res Network Epidemiol & Publ Hlth CIBERESP, Madrid 28034, Spain
[2] Univ Cantabria, Fac Med, E-39005 Santander, Spain
关键词
COMMUNITY-ACQUIRED PNEUMONIA; MOBILE GENETIC ELEMENTS; GRAM-NEGATIVE BACTERIA; COLI RECA PROTEIN; ESCHERICHIA-COLI; PHARMACOGENOMIC STRATEGIES; STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; TRIMETHOPRIM RESISTANCE; PLASMID INCOMPATIBILITY;
D O I
10.1128/AAC.00013-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In recent years, the explosive spread of antibiotic resistance determinants among pathogenic, commensal, and environmental bacteria has reached a global dimension. Classical measures trying to contain or slow locally the progress of antibiotic resistance in patients on the basis of better antibiotic prescribing policies have clearly become insufficient at the global level. Urgent measures are needed to directly confront the processes influencing antibiotic resistance pollution in the microbiosphere. Recent interdisciplinary research indicates that new eco-evo drugs and strategies, which take ecology and evolution into account, have a promising role in resistance prevention, decontamination, and the eventual restoration of antibiotic susceptibility. This minireview summarizes what is known and what should be further investigated to find drugs and strategies aiming to counteract the "four P's," penetration, promiscuity, plasticity, and persistence of rapidly spreading bacterial clones, mobile genetic elements, or resistance genes. The term "drug" is used in this eco-evo perspective as a tool to fight resistance that is able to prevent, cure, or decrease potential damage caused by antibiotic resistance, not necessarily only at the individual level (the patient) but also at the ecological and evolutionary levels. This view offers a wealth of research opportunities for science and technology and also represents a large adaptive challenge for regulatory agencies and public health officers. Eco-evo drugs and interventions constitute a new avenue for research that might influence not only antibiotic resistance but the maintenance of a healthy interaction between humans and microbial systems in a rapidly changing biosphere.
引用
收藏
页码:3649 / 3660
页数:12
相关论文
共 163 条
[1]   Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion [J].
Aiello, Daniel ;
Williams, John D. ;
Majgier-Baranowska, Helena ;
Patel, Ishan ;
Peet, Norton P. ;
Huang, Jin ;
Lory, Stephen ;
Bowlin, Terry L. ;
Moir, Donald T. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) :1988-1999
[2]   Shooting the messenger of antibiotic resistance:: plasmid elimination as a potential counter-evolutionary tactic [J].
Amábile-Cuevas, CF ;
Heinemann, JA .
DRUG DISCOVERY TODAY, 2004, 9 (11) :465-467
[3]  
Askar M, 2011, EUROSURVEILLANCE, V16, P2
[4]   Environmental stress and evolvability in microbial systems [J].
Baquero, F. .
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 :5-10
[5]   Selective compartments for resistant microorganisms in antibiotic gradients [J].
Baquero, F ;
Negri, MC .
BIOESSAYS, 1997, 19 (08) :731-736
[6]   Antibiotic-selective environments [J].
Baquero, F ;
Negri, MC ;
Morosini, MI ;
Blazquez, J .
CLINICAL INFECTIOUS DISEASES, 1998, 27 :S5-S11
[7]  
Baquero F, 2003, ASM NEWS, V69, P547
[8]   Opinion - From pieces to patterns: evolutionary engineering in bacterial pathogens [J].
Baquero, F .
NATURE REVIEWS MICROBIOLOGY, 2004, 2 (06) :510-518
[9]  
BAQUERO F, 2008, INTRO EVOLUTIONARY B, P233
[10]   Antibiotics and antibiotic resistance in water environments [J].
Baquero, Fernando ;
Martinez, Jose-Luis ;
Canton, Rafael .
CURRENT OPINION IN BIOTECHNOLOGY, 2008, 19 (03) :260-265